Efficacy and Safety of High-Dose Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial

Addition of pioglitazone 30 mg/day to T2DM patients who did not reach the target HbA1c (≤7%) with treatment of dapagliflozin 10 mg/day and metformin over 1,000 mg/day showed effective glucose lowering efficacy without significant hypoglycemia and good tolerability with low prevalence of edema in spite of modest weight gain.

Authors

Institutions

Publication Details

Journal
Diabetes & Metabolism Journal
Published
2025-10-28
DOI
https://doi.org/10.4093/dmj.2024.0696
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of High-Dose Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial

Hun‐Sung Kim, Kyong Soo Park, Eui Hyun Kim, Gwanpyo Koh et al.
Diabetes & Metabolism Journal
Diabetes Treatment and Management
article

Efficacy and Safety of High-Dose Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial

Hun‐Sung Kim, Kyong Soo Park, Eui Hyun Kim, Gwanpyo Koh, You‐Cheol Hwang, Jun Hwa Hong, Jong Chul Won, Chang Beom Lee, Hae Jin Kim, Ki Young Ahn, Kyung Ah Han, Eun‐Gyoung Hong, Ho Chan Cho
article en

Abstract

Addition of pioglitazone 30 mg/day to T2DM patients who did not reach the target HbA1c (≤7%) with treatment of dapagliflozin 10 mg/day and metformin over 1,000 mg/day showed effective glucose lowering efficacy without significant hypoglycemia and good tolerability with low prevalence of edema in spite of modest weight gain.

Diabetes & Metabolism JournalVol. 50(2)
Seoul National University (KR), Eulji University (KR), Daegu Fatima Hospital (KR), Inje University Sanggye Paik Hospital (KR), Hanyang University Guri Hospital (KR), Hallym University Dongtan Sacred Heart Hospital (KR), Kyung Hee University Hospital at Gangdong (KR), Jeil Pharmaceutical (South Korea) (KR), The Catholic University of Korea Seoul St. Mary's Hospital (KR), Jeju National University Hospital (KR), Keimyung University (KR), Ajou University (KR), Jeju National University (KR), Catholic University of Korea (KR)
Hanyang University, Catholic University of Daegu, Dongguk University, Kosin University, Kyungpook National University, Seoul National University, Soonchunhyang University, Yonsei University, Hallym University, Inje University, Konkuk University, Korea University, Catholic University of Korea, College of Medicine, Koisin University, Kyungpook National University Hospital, Seoul Metropolitan Government Seoul National University Boramae Medical Center, College of Medicine, Seoul National University, Yonsei University College of Medicine, College of Medicine, Catholic University of Korea, Incheon St. Mary's Hospital, Catholic University of Korea
Openalex Percentile: Top 58%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.